Connection

STEPHEN YENZEN LAI to Mice

This is a "connection" page, showing publications STEPHEN YENZEN LAI has written about Mice.
Connection Strength

0.450
  1. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4652-e4665.
    View in: PubMed
    Score: 0.044
  2. Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer. Br J Cancer. 2021 05; 124(10):1670-1679.
    View in: PubMed
    Score: 0.043
  3. Metabolic interrogation as a tool to optimize chemotherapeutic regimens. Oncotarget. 2017 Mar 14; 8(11):18154-18165.
    View in: PubMed
    Score: 0.032
  4. Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model. Mol Cancer Ther. 2015 Dec; 14(12):2901-8.
    View in: PubMed
    Score: 0.029
  5. Evaluation of hyperpolarized [1-??C]-pyruvate by magnetic resonance to detect ionizing radiation effects in real time. PLoS One. 2014; 9(1):e87031.
    View in: PubMed
    Score: 0.026
  6. Coordinated targeting of the EGFR signaling axis by microRNA-27a*. Oncotarget. 2013 Sep; 4(9):1388-98.
    View in: PubMed
    Score: 0.025
  7. Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma. Oral Oncol. 2012 Dec; 48(12):1220-6.
    View in: PubMed
    Score: 0.023
  8. Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther. 2012 Jun; 11(6):1373-80.
    View in: PubMed
    Score: 0.023
  9. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res. 2011 Apr 15; 17(8):2281-91.
    View in: PubMed
    Score: 0.021
  10. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches. Drug Resist Updat. 2010 Jun; 13(3):67-78.
    View in: PubMed
    Score: 0.020
  11. Effect of perfluorocarbon composition on activation of phase-changing ultrasound contrast agents. Med Phys. 2022 Apr; 49(4):2212-2219.
    View in: PubMed
    Score: 0.011
  12. Comparison of selective excitation and multi-echo chemical shift encoding for imaging of hyperpolarized [1-13C]pyruvate. J Magn Reson. 2021 04; 325:106927.
    View in: PubMed
    Score: 0.011
  13. Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Sci Rep. 2018 03 09; 8(1):4306.
    View in: PubMed
    Score: 0.009
  14. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J. 1996 Sep 02; 15(17):4506-14.
    View in: PubMed
    Score: 0.008
  15. Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma. Oncotarget. 2016 May 03; 7(18):26307-30.
    View in: PubMed
    Score: 0.008
  16. A novel perfused Bloch-McConnell simulator for analyzing the accuracy of dynamic hyperpolarized MRS. Med Phys. 2016 Feb; 43(2):854-64.
    View in: PubMed
    Score: 0.007
  17. Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. Cancer Res. 2015 Nov 15; 75(22):4708-17.
    View in: PubMed
    Score: 0.007
  18. High-throughput hyperpolarized (13)C metabolic investigations using a multi-channel acquisition system. J Magn Reson. 2015 Nov; 260:20-7.
    View in: PubMed
    Score: 0.007
  19. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer. Biomaterials. 2015 Jul; 57:41-9.
    View in: PubMed
    Score: 0.007
  20. Development and characterization of six new human papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab. 2015 Feb; 100(2):E243-52.
    View in: PubMed
    Score: 0.007
  21. Feasibility of multianimal hyperpolarized (13) C MRS. Magn Reson Med. 2015 May; 73(5):1726-32.
    View in: PubMed
    Score: 0.007
  22. Detection of thyroid cancer stem cells in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2014 Feb; 99(2):536-44.
    View in: PubMed
    Score: 0.006
  23. Radial spectroscopic MRI of hyperpolarized [1-(13) C] pyruvate at 7 tesla. Magn Reson Med. 2014 Oct; 72(4):986-95.
    View in: PubMed
    Score: 0.006
  24. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers. J Transl Med. 2013 Aug 27; 11:198.
    View in: PubMed
    Score: 0.006
  25. Src inhibitors in suppression of papillary thyroid carcinoma growth. Head Neck. 2014 Mar; 36(3):375-84.
    View in: PubMed
    Score: 0.006
  26. A throughput-optimized array system for multiple-mouse MRI. NMR Biomed. 2013 Mar; 26(3):237-47.
    View in: PubMed
    Score: 0.006
  27. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma. Clin Cancer Res. 2012 Jan 01; 18(1):127-39.
    View in: PubMed
    Score: 0.006
  28. HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance. Mol Cancer Res. 2011 Mar; 9(3):259-70.
    View in: PubMed
    Score: 0.005
  29. Fast, reproducible measurement of the vascular input function in mice using constrained reconstruction and cardiac sampling. NMR Biomed. 2011 May; 24(4):373-84.
    View in: PubMed
    Score: 0.005
  30. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer. Mol Cancer Ther. 2010 Jul; 9(7):2057-67.
    View in: PubMed
    Score: 0.005
  31. MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo. Mol Cancer Ther. 2010 Jul; 9(7):1968-76.
    View in: PubMed
    Score: 0.005
  32. Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy. In Vivo. 2010 Jan-Feb; 24(1):1-8.
    View in: PubMed
    Score: 0.005
  33. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. J Biol Chem. 1998 Apr 10; 273(15):9255-60.
    View in: PubMed
    Score: 0.002
  34. Redundant and selective roles for erythropoietin receptor tyrosines in erythropoiesis in vivo. Blood. 1998 Feb 01; 91(3):870-8.
    View in: PubMed
    Score: 0.002
  35. Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity. J Biol Chem. 1996 Aug 30; 271(35):21381-90.
    View in: PubMed
    Score: 0.002
  36. Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transduction. J Biol Chem. 1995 Sep 22; 270(38):22176-81.
    View in: PubMed
    Score: 0.002
  37. Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma c chain. J Biol Chem. 1995 Sep 15; 270(37):21729-37.
    View in: PubMed
    Score: 0.002
  38. Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity. Proc Natl Acad Sci U S A. 1995 Aug 01; 92(16):7192-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.